Continuing Enhanced National Surveillance for Prion Diseases in the United States
CDC is funding a specialized center to continue nationwide surveillance and advanced diagnosis of always fatal human prion diseases, ensuring detection of new cases and monitoring for emerging prion diseases in the U.S.
Funder: Centers for Disease Control - NCEZID
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $25,000,000 | Award ceiling: $25,000,000 | Award floor: $3,000,000 | 1 award expected
Summary: Supports a specialized center to conduct enhanced national surveillance and diagnosis of human prion diseases in the United States.
Key Information: This is a forecasted opportunity; all deadlines are projected.
Description
This funding opportunity, offered by the Centers for Disease Control and Prevention’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), aims to continue enhanced national surveillance for human prion diseases (transmissible spongiform encephalopathies, TSEs) in the United States. The program funds a specialized center to conduct state-of-the-art diagnostic techniques, confirm suspected or clinically diagnosed cases, and monitor for potentially emerging prion diseases. The initiative is critical for improving diagnoses, evaluating disease trends, and ensuring accurate national surveillance, especially for always-fatal prion diseases that require brain tissue analyses for confirmation. Since 1997, CDC has supported such a center, enabling the identification of disease subtypes and the monitoring of novel or emerging prion threats.
